Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Reviva Pharmaceuticals Holdings, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +6 vs. Q2 2022
- Shares held
- 920.8K
- −945.6K (−50.7%) vs. Q2 2022
- Total value
- $1.65M
- −$402.0K (−19.6%) vs. Q2 2022
- New holders
- 8
- 2 more added
- Sold out
- 2
- 5 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $3.67K |
| Q1 2026 | 35 | $2.13M |
| Q4 2025 | 48 | $3.17M |
| Q3 2025 | 42 | $3.52M |
| Q2 2025 | 46 | $5.44M |
| Q1 2025 | 49 | $6.95M |
| Q4 2024 | 42 | $14.0M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 31 | $8.75M |
| Q1 2024 | 28 | $21.0M |
| Q4 2023 | 36 | $27.1M |
| Q3 2023 | 24 | $13.0M |
| Q2 2023 | 23 | $15.5M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 23 | $5.54M |
| Q3 2022 | 19 | $1.65M |
| Q2 2022 | 13 | $2.05M |
| Q1 2022 | 16 | $4.68M |
| Q4 2021 | 14 | $7.54M |
| Q3 2021 | 12 | $10.5M |
| Q2 2021 | 12 | $12.8M |
| Q1 2021 | 8 | $3.37M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Reviva Pharmaceuticals Holdings, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 406,394 | $646.0K | 0.00% | −58,414−12.6% | Reduced |
| EMC Capital Management | 55,078 | $275.0K | 0.25% | 00.0% | Unchanged |
| BlackRock Inc. | 83,652 | $133.0K | 0.00% | +83,652 | New |
| Geode Capital Management, LLC | 78,075 | $124.0K | 0.00% | −2,598−3.2% | Reduced |
| Susquehanna International Group, LLP | 72,218 | $115.0K | 0.00% | +72,218 | New |
| Virtu Financial LLC | 46,119 | $73.0K | 0.01% | +46,119 | New |
| Citadel Advisors LLC | 40,232 | $64.0K | 0.00% | +40,232 | New |
| Raymond James & Associates | 33,000 | $52.0K | 0.00% | +13,000+65.0% | Added |
| Sabby Management, LLC | 30,000 | $48.0K | 0.10% | +30,000 | New |
| Simplex Trading, LLC | 22,093 | $35.0K | 0.00% | +22,034+37,345.8% | Added |
| Jane Street Group, LLC | 17,180 | $27.0K | 0.00% | +17,180 | New |
| Quadrature Capital Ltd | 11,839 | $19.0K | 0.00% | +11,839 | New |
| Northern Trust Corp | 10,584 | $17.0K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 9,299 | $15.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,271 | $7.00K | 0.00% | −2,634−38.1% | Reduced |
| Wolverine Asset Management LLC | 659 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| Wells Fargo & Company | 70 | $0 | 0.00% | −1−1.4% | Reduced |
| Royal Bank of Canada | 4 | $0 | 0.00% | +4 | New |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,200,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −18,200−100.0% | Sold out |